On 25 April, Neuronet (a three-year coordination and support action that began in 2019) published its 10th Newsletter. The aim of the Neuronet project was to set up an efficient platform to boost synergy and collaboration across the Innovative Medicines Initiative (IMI) projects of the Neurodegenerative Disorders (ND) portfolio, assisting in identifying gaps, multiplying its impact, enhancing its visibility and facilitating dovetailing with related initiatives in Europe and worldwide. Read the newsletter here: https://bit.ly/Neuronet_Newsletter-10
